“Our T cell-selective lipid nanoparticle (LNP) is designed to overcome a long-standing challenge for siRNA therapeutics, which is to reach T cells while sparing broader immune cells and achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback